Stryker acquired Stanmore Implants from SIW Holdings.
Here are five things to know:
1. Stryker acquired Stanmore for £35.6 million, or around $41 million, in an all-cash transaction.
2. Stanmore focuses on orthopedic oncology implants. The company includes patient-specific and off-the-shelf implants for limb salvage.
3. The acquisition will differentiate technologies for Stryker and underscore the company's commitment to the core joint replacement business as well as expand Stryker's presence in the global orthopedic oncology market.
4. Stryker has been acquiring several companies over the past few months, including closing the acquisition on CareFusion's vertebral compression fracture product portfolio on April 21 and SafeWire's product portfolio on April 11.
5. Stryker reported 4.9 percent net sales growth to $2.5 billion for the first quarter of 2015 and a net earnings increase of 79.5 percent to $402 million. The company is expecting 2016 organic sales growth in the range of 5.5 percent to 6.5 percent.